3 Min.

Research Hospital Charité using ExB Technology to study Fibrosis treatments

Berlin-based university hospital Charité is using cutting edge ExB technologies in its fibrosis research, in order to automate the analysis of tissue sections for early recognition of pathological changes. Doctor-performed histopathological analysis of liver biopsy samples is currently the gold standard for fibrosis, but is also very time-consuming. The research team of Professor Dr. Ingolf Sack und Dr. Korinna Jöhrens at Charité Hospital have high hopes for ExB’s Deep Learning approach to automating image recognition and diagnostic methods and intend to combine them with Charité’s work in elastographic imaging.

Professor Sack is very impressed by the technological possibilities that this cooperative effort opens up: “ExB is spearheading the development of artificial neural networks and Deep Learning applications in medicine. Through strategic cooperation between Charité and ExB, we hope in the future to be able to more quickly and accurately identify and characterize biomarkers.”

For ExB, partnership with Charité is a testament to the strength of its technology. Dr. Ramin Assadollahi, CEO and founder of ExB, emphasizes that “we are very pleased that researchers at Charité are using our technology. In addition to diagnosing hepatic fibrosis, we can bring our high quality Deep Learning processes to bear in the early detection of melanoma and colorectal cancers.”

One platform,
endless possibilities.

ExB is an Intelligent Document Processing platform that transforms unstructured data from any type of document into structured results. Our AI-based software can not only extract all relevant information from your documents, but also understand them. This allows you to automate your processes and save both time & money, while improving your customer experience and employee satisfaction. Win-win. 

Written by:

Dr. Ramin Assadollahi

CEO & Gründer ExB

Dr. Ramin Assadollahi is a computational linguist, inventor and clinical psychologist and is considered one of the AI thought leaders in Germany.
Stay up to date!

Share this post:

This might also interest you:

 | Events

ExB’s top-tier results in the Camelyon Challenge at ISBI 2016 proves that its image analysis technology is able to handle extremely complex diagnostic tasks. The technology compared systems for identifying cancer in lymph node sections in two tasks.

 | Press

Following ExB’s sensational performance at the MICCAI/GlaS Challenge last year, the company’s image processing technology continues its winning streak in international competitions at the ISIC Challenge for automated skin lesion analysis and melanoma detection.

 | Other

Computational linguists and engineers of the Munich-based ExB Group have once again demonstrated the power of their intelligent solutions for Cognitive Computing at the prestigious MultiLing competition for Automated Text Summarization.